Annual EBITDA
-$11.77 M
+$6.95 M+37.13%
September 30, 2024
Summary
- As of March 1, 2025, SONN annual EBITDA is -$11.77 million, with the most recent change of +$6.95 million (+37.13%) on September 30, 2024.
- During the last 3 years, SONN annual EBITDA has risen by +$13.23 million (+52.92%).
- SONN annual EBITDA is now -149.91% below its all-time high of -$4.71 million, reached on September 30, 2019.
Performance
SONN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$2.83 M
+$324.60 K+10.30%
December 31, 2024
Summary
- As of March 1, 2025, SONN quarterly EBITDA is -$2.83 million, with the most recent change of +$324.60 thousand (+10.30%) on December 31, 2024.
- Over the past year, SONN quarterly EBITDA has dropped by -$1.57 million (-124.58%).
- SONN quarterly EBITDA is now -250.81% below its all-time high of -$805.90 thousand, reached on March 31, 2020.
Performance
SONN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$13.33 M
-$1.57 M-13.33%
December 31, 2024
Summary
- As of March 1, 2025, SONN TTM EBITDA is -$13.33 million, with the most recent change of -$1.57 million (-13.33%) on December 31, 2024.
- Over the past year, SONN TTM EBITDA has increased by +$1.05 million (+7.28%).
- SONN TTM EBITDA is now -1554.63% below its all-time high of -$805.90 thousand, reached on March 31, 2020.
Performance
SONN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SONN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +37.1% | -124.6% | +7.3% |
| 3 y3 years | +52.9% | +49.9% | +49.6% |
| 5 y5 years | -149.9% | +49.9% | +49.6% |
SONN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +60.2% | -124.6% | +65.5% | -13.3% | +54.9% |
| 5 y | 5-year | -149.9% | +60.2% | -250.8% | +65.5% | -1554.6% | +54.9% |
| alltime | all time | -149.9% | +60.2% | -250.8% | +65.5% | -1554.6% | +54.9% |
Sonnet BioTherapeutics Holdings EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | -$2.83 M(-10.3%) | -$13.33 M(+13.3%) |
| Sep 2024 | -$11.77 M(-37.1%) | -$3.15 M(-10.1%) | -$11.77 M(-3.5%) |
| Jun 2024 | - | -$3.51 M(-8.8%) | -$12.20 M(-3.1%) |
| Mar 2024 | - | -$3.85 M(+205.7%) | -$12.58 M(-12.5%) |
| Dec 2023 | - | -$1.26 M(-64.8%) | -$14.38 M(-23.2%) |
| Sep 2023 | -$18.72 M(-36.7%) | -$3.58 M(-8.1%) | -$18.72 M(-16.8%) |
| Jun 2023 | - | -$3.90 M(-31.0%) | -$22.50 M(-14.9%) |
| Mar 2023 | - | -$5.65 M(+0.9%) | -$26.44 M(-8.8%) |
| Dec 2022 | - | -$5.59 M(-24.0%) | -$28.98 M(-2.0%) |
| Sep 2022 | -$29.58 M | -$7.36 M(-6.2%) | -$29.58 M(+1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$7.84 M(-4.2%) | -$29.14 M(+5.9%) |
| Mar 2022 | - | -$8.18 M(+32.2%) | -$27.51 M(+8.6%) |
| Dec 2021 | - | -$6.19 M(-10.6%) | -$25.34 M(+1.4%) |
| Sep 2021 | -$24.99 M(+44.0%) | -$6.92 M(+11.4%) | -$24.99 M(-2.1%) |
| Jun 2021 | - | -$6.22 M(+3.4%) | -$25.54 M(+5.3%) |
| Mar 2021 | - | -$6.01 M(+2.9%) | -$24.26 M(+27.3%) |
| Dec 2020 | - | -$5.84 M(-21.8%) | -$19.06 M(+44.2%) |
| Sep 2020 | -$17.35 M(+268.6%) | -$7.47 M(+51.2%) | -$13.21 M(+130.0%) |
| Jun 2020 | - | -$4.94 M(+513.0%) | -$5.75 M(+613.0%) |
| Mar 2020 | - | -$805.90 K | -$805.90 K |
| Sep 2019 | -$4.71 M | - | - |
FAQ
- What is Sonnet BioTherapeutics Holdings annual EBITDA?
- What is the all time high annual EBITDA for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings annual EBITDA year-on-year change?
- What is Sonnet BioTherapeutics Holdings quarterly EBITDA?
- What is the all time high quarterly EBITDA for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings quarterly EBITDA year-on-year change?
- What is Sonnet BioTherapeutics Holdings TTM EBITDA?
- What is the all time high TTM EBITDA for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings TTM EBITDA year-on-year change?
What is Sonnet BioTherapeutics Holdings annual EBITDA?
The current annual EBITDA of SONN is -$11.77 M
What is the all time high annual EBITDA for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high annual EBITDA is -$4.71 M
What is Sonnet BioTherapeutics Holdings annual EBITDA year-on-year change?
Over the past year, SONN annual EBITDA has changed by +$6.95 M (+37.13%)
What is Sonnet BioTherapeutics Holdings quarterly EBITDA?
The current quarterly EBITDA of SONN is -$2.83 M
What is the all time high quarterly EBITDA for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high quarterly EBITDA is -$805.90 K
What is Sonnet BioTherapeutics Holdings quarterly EBITDA year-on-year change?
Over the past year, SONN quarterly EBITDA has changed by -$1.57 M (-124.58%)
What is Sonnet BioTherapeutics Holdings TTM EBITDA?
The current TTM EBITDA of SONN is -$13.33 M
What is the all time high TTM EBITDA for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high TTM EBITDA is -$805.90 K
What is Sonnet BioTherapeutics Holdings TTM EBITDA year-on-year change?
Over the past year, SONN TTM EBITDA has changed by +$1.05 M (+7.28%)